FDA Drug Application (203277) for LAMIVUDINE by HETERO LABS LTD V

Back to FDA Applications sponsored by HETERO LABS LTD V

Application Number203277
Product Number001
FormTABLET;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLAMIVUDINE
Active IngredientLAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by HETERO LABS LTD V